Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Can PTSC survive DL without dilution? Not unless DL gives it up.

<No matter what happens the BOD can always do a dilutive private placement.>

And that puts PTSC at a disadvantage? Sorry having some difficulty with your logic. Why do you make the assumption that TPL has money coming out the kazoo? And why would Leckrone not be concerned about making those serious charges go away?

Opty

Share
New Message
Please login to post a reply